TY - JOUR
T1 - A novel porous hydrogel based on hybrid gelation for injectable and tough scaffold implantation and tissue engineering applications
AU - Hidalgo, Carmen
AU - Méndez-Ruette, Maxs
AU - Zavala, Gabriela
AU - Viafara-García, Sergio
AU - Novoa, Javier
AU - Díaz-Calderón, Paulo
AU - González-Arriagada, Wilfredo Alejandro
AU - Cuenca, Jimena
AU - Khoury, Maroun
AU - Acevedo Cox, Juan Pablo
N1 - Publisher Copyright:
© 2023 IOP Publishing Ltd
PY - 2023/5/24
Y1 - 2023/5/24
N2 - Although there have been many advances in injectable hydrogels as scaffolds for tissue engineering or as payload-containing vehicles, the lack of adequate microporosity for the desired cell behavior, tissue integration, and successful tissue generation remains an important drawback. Herein, we describe an effective porous injectable system that allows in vivo formation of pores through conventional syringe injection at room temperature. This system is based on the differential melting profiles of photocrosslinkable salmon gelatin and physically crosslinked porogens of porcine gelatin, in which porcine gelatin porogens are solid beads, while salmon methacrylamide gelatin remains liquid during the injection procedure. After injection and photocrosslinking, the porogens were degraded in response to the physiological temperature, enabling the generation of a homogeneous porous structure within the hydrogel. The resultant porous formulations exhibited controlled gelation kinetics within a broad temperature window (18.5 ± 0.5 - 28.8 ± 0.8 °C), low viscosity (133 ± 1.4 - 188 ± 16 cP ), low force requirements for injectability (17 ± 0.3 - 39 ± 1 N), robust mechanical properties (100.9 ± 3.4 - 332 ± 13.2 kPa), and favorable cytocompatibility (>70 % cell viability). Remarkably, in vivo subcutaneous injection demonstrated the suitability of the system with appropriate viscosity and swift crosslinking to generate porous hydrogels. The resulting injected porous constructs showed favorable biocompatibility and facilitated cell infiltration for desirable tissue remodeling. Finally, the porous formulations exhibited favorable handling, easy deposition, and good shape fidelity when used as bioinks in 3D bioprinting technology. This injectable porous system serves as a platform for various biomedical applications, thereby inspiring future advances in cell therapy and tissue engineering.
AB - Although there have been many advances in injectable hydrogels as scaffolds for tissue engineering or as payload-containing vehicles, the lack of adequate microporosity for the desired cell behavior, tissue integration, and successful tissue generation remains an important drawback. Herein, we describe an effective porous injectable system that allows in vivo formation of pores through conventional syringe injection at room temperature. This system is based on the differential melting profiles of photocrosslinkable salmon gelatin and physically crosslinked porogens of porcine gelatin, in which porcine gelatin porogens are solid beads, while salmon methacrylamide gelatin remains liquid during the injection procedure. After injection and photocrosslinking, the porogens were degraded in response to the physiological temperature, enabling the generation of a homogeneous porous structure within the hydrogel. The resultant porous formulations exhibited controlled gelation kinetics within a broad temperature window (18.5 ± 0.5 - 28.8 ± 0.8 °C), low viscosity (133 ± 1.4 - 188 ± 16 cP ), low force requirements for injectability (17 ± 0.3 - 39 ± 1 N), robust mechanical properties (100.9 ± 3.4 - 332 ± 13.2 kPa), and favorable cytocompatibility (>70 % cell viability). Remarkably, in vivo subcutaneous injection demonstrated the suitability of the system with appropriate viscosity and swift crosslinking to generate porous hydrogels. The resulting injected porous constructs showed favorable biocompatibility and facilitated cell infiltration for desirable tissue remodeling. Finally, the porous formulations exhibited favorable handling, easy deposition, and good shape fidelity when used as bioinks in 3D bioprinting technology. This injectable porous system serves as a platform for various biomedical applications, thereby inspiring future advances in cell therapy and tissue engineering.
KW - Biocompatible Materials/chemistry
KW - Gelatin/chemistry
KW - Hydrogels/chemistry
KW - Porosity
KW - Printing, Three-Dimensional
KW - Tissue Engineering/methods
KW - Tissue Scaffolds/chemistry
UR - http://www.scopus.com/inward/record.url?scp=85160009496&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/4996bbc2-2c0c-34e5-b967-729df75f0364/
U2 - 10.1088/1748-605X/acd499
DO - 10.1088/1748-605X/acd499
M3 - Article
C2 - 37167997
SN - 1748-6041
VL - 18
JO - Biomedical Materials (Bristol)
JF - Biomedical Materials (Bristol)
IS - 4
M1 - 045014
ER -